CENTENE CORP lags behind the market

Trending News 🌧️

Centene Corp Stock Intrinsic Value – CENTENE CORP ($NYSE:CNC) is a health care company that provides services to government-sponsored health care programs. The company’s stock was up Tuesday, but it still lagged behind the broader market. One reason for this may be that investors are concerned about the company’s ability to grow its business.

In addition, the company faces stiff competition from other health care companies.

Price History

On Wednesday, CENTENE CORP stock opened at $75.3 and closed at $75.7, up by 0.5% from prior closing price of 75.3. CENTENE CORP is a healthcare company that provides services to government-sponsored healthcare programs. The company has been underperforming the market in recent months, due in part to concerns about its exposure to the Affordable Care Act.

Investors are also worried about the company’s ability to maintain its profitability as it expands into new markets. The company is scheduled to release its fourth quarter earnings on Thursday, and analysts will be closely watching to see if it can turn things around.

VI Analysis – Centene Corp Stock Intrinsic Value

CENTENE CORP‘s fundamentals reflect the company’s long-term potential, as indicated by the VI app. The app calculates the fair value of CENTENE CORP shares to be around $83.2. However, the stock is currently traded at $75.7, which represents a 9% discount to the fair value.

VI Peers

In the healthcare industry, competition is fierce between Centene Corp and its major competitors UnitedHealth Group Inc, Pacific Health Care Organization Inc, and Humana Inc. All four companies are constantly striving to innovate and offer the best products and services to their customers. This competition is good for consumers because it drives down prices and improves the quality of care.

– UnitedHealth Group Inc ($NYSE:UNH)

The company’s market cap is 486.7B as of 2022 and its ROE is 21.75%. The company is a diversified health and well-being company that serves more than 115 million consumers in the United States. The company offers a wide range of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services.

– Pacific Health Care Organization Inc ($OTCPK:PFHO)

As of 2022, Pacific Health Care Organization Inc has a market cap of 10.11M and a Return on Equity of 1.33%. The company is a healthcare provider that offers services such as primary care, mental health, and substance abuse treatment.

– Humana Inc ($NYSE:HUM)

Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky. As of 2019, Humana is ranked #4 in the United States by revenue. It has over 13 million customers in the United States. The company sells health insurance plans for individuals, families, Medicare, and employer groups. It also offers dental, vision, and other insurance products.

Summary

There are a number of reasons why investing in CENTENE CORP may not be the best idea at the moment. For one, the company lags behind the market in terms of key performance indicators. Additionally, the company is facing a number of headwinds, including increased competition, regulatory pressures, and declining Medicaid enrollment. As such, investors may want to consider other options before investing in CENTENE CORP.